The consequences of epigenetic drugs in the treatment of AML
Treatment for older AML patients - when is an allogeneic transplant suitable?
Good nursing care is the key to veno-occlusive disease (VOD) management
Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)
Why do charities need to keep funding research into leukemia and blood cancer in general?